Affiliation:
1. INSERM U1144: Optimisation Therapeutique en Neuropsychopharmacologie
2. INSERM U1148: Laboratoire de Recherche Vasculaire Translationnelle
3. Institut Gustave-Roussy: Gustave Roussy
4. Universität Würzburg: Julius-Maximilians-Universitat Wurzburg
5. Unité Inserm 1255: Biologie et Pharmacologie des Plaquettes Sanguines Hemostase Thrombose Transfusion
Abstract
Abstract
Background
How platelets interact with and influence the tumor microenvironment (TME) remains poorly characterized.
Methods
We compared the presence and participation of platelets in the TME of two tumors characterized by highly different TME, PyMT AT-3 mammary tumors and B16F1 melanoma.
Results
We show that whereas firmly adherent platelets continuously line tumor vessels of both AT-3 and B16F1 tumors, abundant extravascular stromal clusters of platelets from thrombopoietin-independent origin were present only in AT-3 mammary tumors. We further show that platelets influence the angiogenic and inflammatory profiles of AT-3 and B16F1 tumors, though with very different outcomes according to tumor type. Whereas thrombocytopenia increased bleeding in both tumor types, it further caused severe endothelial degeneration associated with massive vascular leakage, tumor swelling, and increased infiltration of cytotoxic cells, only in AT-3 tumors.
Conclusions
These results indicate that while platelets are integral components of solid tumors, their localization and origin in the TME, as well as their impact on its shaping, are tumor type-dependent.
Publisher
Research Square Platform LLC